Screener
Merck & Co. MRK Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:11 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0000310158-26-000212
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 2,904 | 2,649 | 5,604 | 5,202 |
| Research and development | 9,741 | 4,048 | 22,333 | 7,669 |
| Restructuring costs | 151 | 560 | 346 | 629 |
| Other (income) expense, net | 99 | (7) | 237 | (43) |
| 17,290 | 10,807 | 37,110 | 20,433 | |
| (Loss) Income Before Taxes | (683) | 4,999 | (4,217) | 10,902 |
| Income Tax Provision | 654 | 571 | 1,363 | 1,388 |
| Net (Loss) Income | (1,337) | 4,428 | (5,580) | 9,514 |
Item 1. Financial Statements
FAQ
- What is Merck & Co.'s other income (expense)?
- Merck & Co. (MRK) reported other income (expense) of -$99M in Q2 2026.
- How has Merck & Co.'s other income (expense) changed year-over-year?
- Merck & Co.'s other income (expense) decreased by 1514.3% year-over-year, from $7M to -$99M.
- What is the long-term trend for Merck & Co.'s other income (expense)?
- Over 2 years (2021 to 2023), Merck & Co.'s other income (expense) has grown at a -41.1% compound annual growth rate (CAGR), from $1.34B to -$466M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Merck & Co.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude